Hims and Hers Health Inc vs iShares Core MSCI EAFE ETF — how do they compare? Hims and Hers Health Inc trades at $32.43 (market cap $7.57B), while iShares Core MSCI EAFE ETF trades at $96.99. The key difference: iShares Core MSCI EAFE ETF is trading nearer its 52-week high, Hims and Hers Health Inc nearer its low. Which is the better fit depends on your goals.
| HIMS | IEFA | |
|---|---|---|
Market Cap | $7.57B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $66.18 | $98.56 |
52-Week Low | $14.52 | $81.70 |
Enterprise Value | $7.95B | — |
Signals from Pluang's Aura AI — not financial advice
Hims & Hers Health trades at $32.70, down 0.43% on the day, with a bearish technical signal despite bullish moving averages. The company reported $2.35 billion in 2025 revenue but swung to a projected net loss for 2026, with mixed quarterly earnings results. Recent news highlights executive changes and anticipation for Q2 2026 results on August 10, 2026, with analyst sentiment leaning toward a Buy consensus.
The outlook is cautious due to profitability concerns and high valuation multiples, but growth opportunities in weight-loss and telehealth services offer potential. Key risks include execution challenges and regulatory scrutiny. The stock presents a speculative growth play with a consensus price target of $33.57, slightly above the current price.
No Aura AI signal available yet.
Trailing returns across standard periods
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →IEFA tracks the MSCI EAFE Investable Market Index, offering broad exposure to large, mid, and small-cap stocks in developed markets across Europe, Australasia, and the Far East. It serves as a low-cost core holding for international diversification, excluding the U.S. and Canada.
Read more on IEFA →